{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:54:02Z","timestamp":1792799642035,"version":"4.5.0"},"reference-count":13,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"National Institutes of Health Intramural Research Program"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Numerous laboratory tests are used in the diagnosis and management of patients with diabetes mellitus. The quality of the scientific evidence supporting the use of these assays varies substantially. An expert committee compiled evidence-based recommendations for laboratory analysis in patients with diabetes. The overall quality of the evidence and the strength of the recommendations were evaluated. The draft consensus recommendations were evaluated by invited reviewers and presented for public comment. Suggestions were incorporated as deemed appropriate by the authors (see Acknowledgments in the full version of the guideline). The guidelines were reviewed by the Evidence Based Laboratory Medicine Committee and the Board of Directors of the American Association for Clinical Chemistry and by the Professional Practice Committee of the American Diabetes Association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONTENT<\/jats:title>\n                    <jats:p>Diabetes can be diagnosed by demonstrating increased concentrations of glucose in venous plasma or increased hemoglobin A1c (HbA1c) in the blood. Glycemic control is monitored by the patients measuring their own blood glucose with meters and\/or with continuous interstitial glucose monitoring devices and also by laboratory analysis of HbA1c. The potential roles of noninvasive glucose monitoring; genetic testing; and measurement of ketones, autoantibodies, urine albumin, insulin, proinsulin, and C-peptide are addressed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY<\/jats:title>\n                    <jats:p>The guidelines provide specific recommendations based on published data or derived from expert consensus. Several analytes are found to have minimal clinical value at the present time, and measurement of them is not recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dci23-0048","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T13:07:47Z","timestamp":1689858467000},"page":"1740-1746","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":32,"title":["Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus"],"prefix":"10.2337","volume":"46","author":[{"given":"David B.","family":"Sacks","sequence":"first","affiliation":[{"name":"1Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Arnold","sequence":"additional","affiliation":[{"name":"2Department of Chemistry, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-1267","authenticated-orcid":false,"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[{"name":"3Department of Medicine, American Heart Association Comprehensive Hypertension Center, Section of Endocrinology, Diabetes and Metabolism, University of Chicago Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Bruns","sequence":"additional","affiliation":[{"name":"4Department of Pathology, University of Virginia Medical School, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Horvath","sequence":"additional","affiliation":[{"name":"5New South Wales Health Pathology Department of Chemical Pathology, Prince of Wales Hospital, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0499","authenticated-orcid":false,"given":"\u00c5ke","family":"Lernmark","sequence":"additional","affiliation":[{"name":"6Department of Clinical Sciences, Lund University\/CRC, Skane University Hospital Malm\u00f6, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6503-1962","authenticated-orcid":false,"given":"Boyd E.","family":"Metzger","sequence":"additional","affiliation":[{"name":"7Division of Endocrinology, Northwestern University, The Feinberg School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nathan","sequence":"additional","affiliation":[{"name":"8Massachusetts General Hospital Diabetes Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-9609","authenticated-orcid":false,"given":"M. Sue","family":"Kirkman","sequence":"additional","affiliation":[{"name":"9Department of Medicine, University of North Carolina, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"2023092018511985500_B1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.iy.08.040190.003243","article-title":"Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat","volume":"8","author":"Casta\u00f1o","year":"1990","journal-title":"Annu Rev Immunol"},{"key":"2023092018511985500_B2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"2023092018511985500_B3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ajcp\/105.2.149","article-title":"The pathogenesis of type II diabetes mellitus. A polygenic disease","volume":"105","author":"Sacks","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"2023092018511985500_B4","unstructured":"International Diabetes Federation\n          . IDF Diabetes Atlas. 10th ed.2021. Accessed 23 May 2022. Available from https:\/\/diabetesatlas.org\/idfawp\/resource-files\/2021\/07\/IDF_Atlas_10th_Edition_2021.pdf"},{"key":"2023092018511985500_B5","unstructured":"Centers for Disease Control and Prevention\n          . National Diabetes Statistics Report, 2022. Accessed 9 August 2022. Available from https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html"},{"key":"2023092018511985500_B6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the U.S. in 2017","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"2023092018511985500_B7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/dc08-9017","article-title":"Economic costs of diabetes in the U.S. in 2007","volume":"31","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"key":"2023092018511985500_B8","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2337\/diacare.28.9.2130","article-title":"The burden of mortality attributable to diabetes: realistic estimates for the year 2000","volume":"28","author":"Roglic","year":"2005","journal-title":"Diabetes Care"},{"key":"2023092018511985500_B9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2337\/diacare.25.4.750","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"25","author":"Sacks","year":"2002","journal-title":"Diabetes Care"},{"key":"2023092018511985500_B10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/clinchem\/48.3.436","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"48","author":"Sacks","year":"2002","journal-title":"Clin Chem"},{"key":"2023092018511985500_B11","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.2337\/dc11-9998","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"2023092018511985500_B12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1373\/clinchem.2010.161596","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"57","author":"Sacks","year":"2011","journal-title":"Clin Chem"},{"key":"2023092018511985500_B13","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.2337\/dci23-0036","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"46","author":"Sacks","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/10\/1740\/734759\/dci230048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/10\/1740\/734759\/dci230048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T14:54:43Z","timestamp":1695221683000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/46\/10\/1740\/153424\/Executive-Summary-Guidelines-and-Recommendations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":13,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,7,20]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci23-0048","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}